These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7902628)

  • 1. Autologous neutralizing antibodies to SIVsm in cynomolgus monkeys correlate to prognosis.
    Zhang YJ; Ohman P; Putkonen P; Albert J; Walther L; Stålhandske P; Biberfeld G; Fenyö EM
    Virology; 1993 Dec; 197(2):609-15. PubMed ID: 7902628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable biological and antigenic characteristics of HIV-2SBL6669 in nonpathogenic infection of macaques.
    Zhang YJ; Putkonen P; Albert J; Ohman P; Biberfeld G; Fenyö EM
    Virology; 1994 May; 200(2):583-9. PubMed ID: 7909969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative studies on mucosal and intravenous transmission of simian immunodeficiency virus (SIVsm): the kinetics of evolution to neutralization resistance are related to progression rate of disease.
    Laurén A; Thorstensson R; Fenyö EM
    J Gen Virol; 2006 Mar; 87(Pt 3):595-606. PubMed ID: 16476980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4-independent use of the CCR5 receptor by sequential primary SIVsm isolates.
    Laurén A; Vincic E; Hoshino H; Thorstensson R; Fenyö EM
    Retrovirology; 2007 Jul; 4():50. PubMed ID: 17645788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plateau levels of viremia correlate with the degree of CD4+-T-cell loss in simian immunodeficiency virus SIVagm-infected pigtailed macaques: variable pathogenicity of natural SIVagm isolates.
    Goldstein S; Ourmanov I; Brown CR; Plishka R; Buckler-White A; Byrum R; Hirsch VM
    J Virol; 2005 Apr; 79(8):5153-62. PubMed ID: 15795299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
    Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postinfection passive transfer of KD-247 protects against simian/human immunodeficiency virus-induced CD4+ T-cell loss in macaque lymphoid tissue.
    Murakami T; Eda Y; Nakasone T; Ami Y; Someya K; Yoshino N; Kaizu M; Izumi Y; Matsui H; Shinohara K; Yamamoto N; Honda M
    AIDS; 2009 Jul; 23(12):1485-94. PubMed ID: 19528788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses.
    Reimann KA; Watson A; Dailey PJ; Lin W; Lord CI; Steenbeke TD; Parker RA; Axthelm MK; Karlsson GB
    Virology; 1999 Mar; 256(1):15-21. PubMed ID: 10087222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
    J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic variation of molecularly cloned SIVmac239 during persistent infection in a rhesus macaque.
    Joag SV; Anderson MG; Clements JE; McEntee MF; Sharma DP; Adams RJ; Narayan O
    Virology; 1993 Aug; 195(2):406-12. PubMed ID: 8337820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and predictive markers of disease progression in cynomolgus monkeys experimentally infected with simian immunodeficiency virus.
    Putkonen P; Kaaya EE; Böttiger D; Li SL; Nilsson C; Biberfeld P; Biberfeld G
    AIDS; 1992 Mar; 6(3):257-63. PubMed ID: 1348944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad cross-neutralizing activity in serum is associated with slow progression and low risk of transmission in primate lentivirus infections.
    Fenyö EM; Putkonen P
    Immunol Lett; 1996 Jun; 51(1-2):95-9. PubMed ID: 8811351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric dengue type 2/type 1 viruses induce immune responses in cynomolgus monkeys.
    Butrapet S; Rabablert J; Angsubhakorn S; Wiriyarat W; Huang C; Kinney R; Punyim S; Bhamarapravati N
    Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):589-99. PubMed ID: 12693596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell-mediated protective efficacy of a systemic vaccine approach in cynomolgus monkeys after SIV mucosal challenge.
    Michelini Z; Negri DR; Baroncelli S; Catone S; Comini A; Maggiorella MT; Sernicola L; Crostarosa F; Belli R; Mancini MG; Farcomeni S; Fagrouch Z; Ciccozzi M; Rovetto C; Liljestrom P; Norley S; Heeney J; Titti F
    J Med Primatol; 2004 Oct; 33(5-6):251-61. PubMed ID: 15525326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection with a molecularly cloned SIVsm virus elicits high titer homologous neutralizing antibodies with heterologous neutralizing activity.
    Mahalanabis M; Hirsch VM; Haigwood NL
    J Med Primatol; 2005 Oct; 34(5-6):253-61. PubMed ID: 16128920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmas from lymphocyte- and macrophage-tropic SIVmac-infected macaques have antibodies with a broader spectrum of virus neutralization activity in macrophage versus lymphocyte cultures.
    Zhuge W; Jia F; Adany I; Narayan O; Stephens EB
    Virology; 1997 Jan; 227(1):24-33. PubMed ID: 9007055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiprotein genetic vaccine in the SIV-Macaca animal model: a promising approach to generate sterilizing immunity to HIV infection.
    Maggiorella MT; Sernicola L; Crostarosa F; Belli R; Pavone-Cossut MR; Macchia I; Farcomeni S; Tenner-Racz K; Racz P; Ensoli B; Titti F
    J Med Primatol; 2007 Aug; 36(4-5):180-94. PubMed ID: 17669207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic dendritic-cell vaccine for simian AIDS.
    Lu W; Wu X; Lu Y; Guo W; Andrieu JM
    Nat Med; 2003 Jan; 9(1):27-32. PubMed ID: 12496959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristic immunodeficiency syndrome of rapid fatal type of simian immunodeficiency virus infected monkeys].
    Wu X; Lu Y; He F; Qing C; Song H; Cong Z; Tong W
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):71-4. PubMed ID: 12903498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viremia, antigenemia, and serum antibodies in rhesus macaques infected with simian retrovirus type 1 and their relationship to disease course.
    Kwang HS; Pedersen NC; Lerche NW; Osborn KG; Marx PA; Gardner MB
    Lab Invest; 1987 Jun; 56(6):591-7. PubMed ID: 3599907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.